These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32862481)

  • 1. Is race or ethnicity associated with under-utilization of statins among women in the United States: The study of women's health across the nation.
    Jackson EA; Ruppert K; Derby CA; Lian Y; Chae CU; Kazlauskaite R; Neal-Perry G; El Khoudary SR; Harlow SD; Solomon DH
    Clin Cardiol; 2020 Dec; 43(12):1388-1397. PubMed ID: 32862481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US: National Health and Nutrition Examination Surveys, 2013 to March 2020.
    Jacobs JA; Addo DK; Zheutlin AR; Derington CG; Essien UR; Navar AM; Hernandez I; Lloyd-Jones DM; King JB; Rao S; Herrick JS; Bress AP; Pandey A
    JAMA Cardiol; 2023 May; 8(5):443-452. PubMed ID: 36947031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethnic differences in guideline-indicated statin initiation for people with type 2 diabetes in UK primary care, 2006-2019: A cohort study.
    Eastwood SV; Mathur R; Sattar N; Smeeth L; Bhaskaran K; Chaturvedi N
    PLoS Med; 2021 Jun; 18(6):e1003672. PubMed ID: 34185782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Pooled Cohort Risk Equations for Cardiovascular Risk Prediction in a Multiethnic Cohort From the Women's Health Initiative.
    Mora S; Wenger NK; Cook NR; Liu J; Howard BV; Limacher MC; Liu S; Margolis KL; Martin LW; Paynter NP; Ridker PM; Robinson JG; Rossouw JE; Safford MM; Manson JE
    JAMA Intern Med; 2018 Sep; 178(9):1231-1240. PubMed ID: 30039172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of Atherosclerotic Cardiovascular Disease Risk Among Patients in the Veterans Affairs Health Care System.
    Vassy JL; Lu B; Ho YL; Galloway A; Raghavan S; Honerlaw J; Tarko L; Russo J; Qazi S; Orkaby AR; Tanukonda V; Djousse L; Gaziano JM; Gagnon DR; Cho K; Wilson PWF
    JAMA Netw Open; 2020 Jul; 3(7):e208236. PubMed ID: 32662843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in statin utilization and lipid lowering by race, ethnicity, and HIV status in a real-world cohort of persons with human immunodeficiency virus and uninfected persons.
    Riestenberg RA; Furman A; Cowen A; Pawlowksi A; Schneider D; Lewis AA; Kelly S; Taiwo B; Achenbach C; Palella F; Stone NJ; Lloyd-Jones DM; Feinstein MJ
    Am Heart J; 2019 Mar; 209():79-87. PubMed ID: 30685678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.
    Yeboah J; Polonsky TS; Young R; McClelland RL; Delaney JC; Dawood F; Blaha MJ; Miedema MD; Sibley CT; Carr JJ; Burke GL; Goff DC; Psaty BM; Greenland P; Herrington DM
    Circulation; 2015 Sep; 132(10):916-22. PubMed ID: 26224808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further insight into the cardiovascular risk calculator: the roles of statins, revascularizations, and underascertainment in the Women's Health Study.
    Cook NR; Ridker PM
    JAMA Intern Med; 2014 Dec; 174(12):1964-71. PubMed ID: 25285455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease.
    Rodriguez F; Maron DJ; Knowles JW; Virani SS; Lin S; Heidenreich PA
    JAMA Cardiol; 2017 Jan; 2(1):47-54. PubMed ID: 27829091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Trends in Statin Therapy for Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults From 2007 to 2016.
    Yao X; Shah ND; Gersh BJ; Lopez-Jimenez F; Noseworthy PA
    JAMA Netw Open; 2020 Nov; 3(11):e2025505. PubMed ID: 33216139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of incident diabetes on atherosclerotic cardiovascular disease according to statin use history among postmenopausal women.
    Ma Y; Persuitte GM; Andrews C; Hovey KM; LaMonte MJ; Culver AL; Manson JE; Phillips LS; Liu S; Eaton C; Martin LW; Howard BV; Balasubramanian R; Bird CE; Ockene IS; Sturgeon SR; Ockene JK; Tinker L; Nassir R; Rossouw J
    Eur J Epidemiol; 2016 Aug; 31(8):747-61. PubMed ID: 27188186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns and gaps in guideline-directed statin use for atherosclerotic cardiovascular disease by race and ethnicity.
    Sarraju A; Yan X; Huang Q; Dudum R; Palaniappan L; Rodriguez F
    Am J Prev Cardiol; 2024 Mar; 17():100647. PubMed ID: 38525197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin Use in Older Adults for Primary Cardiovascular Disease Prevention Across a Spectrum of Cardiovascular Risk.
    Sarraju A; Spencer-Bonilla G; Chung S; Gomez S; Li J; Heidenreich P; Palaniappan L; Rodriguez F
    J Gen Intern Med; 2022 Aug; 37(11):2642-2649. PubMed ID: 34505981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in statin prescription among veterans with HIV and known atherosclerotic cardiovascular disease.
    Erqou S; Papaila A; Halladay C; Ge A; Liu MA; Jiang L; Lally M; Menon A; Shah NR; Miech E; Virani SS; Zullo AR; Shireman TI; Longenecker CT; Ross D; Sullivan JL; Wu WC; Rudolph JL
    Am Heart J; 2022 Jul; 249():12-22. PubMed ID: 35318028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual Hypertriglyceridemia and Estimated Atherosclerotic Cardiovascular Disease Risk by Statin Use in U.S. Adults With Diabetes: National Health and Nutrition Examination Survey 2007-2014.
    Fan W; Philip S; Granowitz C; Toth PP; Wong ND
    Diabetes Care; 2019 Dec; 42(12):2307-2314. PubMed ID: 31575639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of the US cholesterol guidelines on eligibility for statin therapy in the community: comparison of observed and predicted risks in the Framingham Heart Study Offspring Cohort.
    Andersson C; Enserro D; Larson MG; Xanthakis V; Vasan RS
    J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25888372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Race/Ethnic and Sex Differences in the Association of Atherosclerotic Cardiovascular Disease Risk and Healthy Lifestyle Behaviors.
    Morris AA; Ko YA; Hutcheson SH; Quyyumi A
    J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29728015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-Year Residual Atherosclerotic Cardiovascular Disease Risk Prediction Model for Statin Treated Patients With Known Cardiovascular Disease.
    Wong ND; Zhao Y; Xiang P; Coll B; López JAG
    Am J Cardiol; 2020 Dec; 137():7-11. PubMed ID: 32991855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective examination of lipid-lowering treatment patterns in a real-world high-risk cohort in the UK in 2014: comparison with the National Institute for Health and Care Excellence (NICE) 2014 lipid modification guidelines.
    Steen DL; Khan I; Ansell D; Sanchez RJ; Ray KK
    BMJ Open; 2017 Feb; 7(2):e013255. PubMed ID: 28213597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Race and Ethnicity on Antihypertensive Medication Utilization Among Women in the United States: Study of Women's Health Across the Nation (SWAN).
    Jackson EA; Ruppert K; Derby CA; Lian Y; Neal-Perry G; Habel LA; Tepper PG; Harlow SD; Solomon DH
    J Am Heart Assoc; 2017 Feb; 6(3):. PubMed ID: 28232324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.